SUMMARY Methicillin-resistant staphylococci were tested for susceptibility to cephradine, cephaloridine, cephalexin, and cefuroxime at 30°C and 37°C on ordinary media and on media of enhanced osmotic strength. The coagulase-negative strains were divided into Staphylococcus epidermidis and Staphylococcus hominis. Generally the number of susceptible strains decreased with low incubation temperature Figure. The ranges of final concentrations of antibiotics tested were cephalexin, cephradine, and cefuroxime, 2-64 mg/l, and cephaloridine, 0-5-16 mg/l. After viability had been checked the minimum inhibitory concentrations (MIC) of the organisms were read in the usual way. Strains were considered to be susceptible when the MIC did not exceed 16 mg/l in the case of cephradine, cephalexin, and cefuroxime, and 4 mg/l in the case of cephaloridine.
The use of an incubation temperature of 30'C rather than 370C when testing Staphylococcus aureus for susceptibility to methicillin, or alternatively the addition of sodium chloride to the test medium if the higher temperature is used, results in the detection of more resistant strains.'2 Though cephalosporins also exert their effects on the cell walls of bacteria, investigation into the use of low incubation temperature when testing for susceptibility to these drugs, with or without osmotic support, has been limited. [3] [4] [5] Coagulase-negative staphylococci (Staphylococcus albus) are now recognised as potential causes of sepsis in patients whose immune responses are compromised or who have surgically implanted devices such as cardiac valve replacements, hydrocephalus shunts, and artificial joints. Strains of Staph. albus have been shown to be multi-resistant6 7 and often resistant to methicillin.8 Because of this, the use of cephalosporins in the treatment of infections due to methicillin-resistant staphylococci has been considered, though cross resistance between methicillin and cephalosporins has been suggested. 9 We therefore investigated the susceptibility of methicillin-resistant strains of Staph. aureus and Staph. albus to cephradine, cephalexin, cephaloridine, and cefuroxime, using low incubation temAccepted for publication 28 May 1980 peratures and osmotic support in addition to a conventional agar plate method. All coagulase-negative staphylococci were fully identified as it was considered possible that differences in antibiotic susceptibility might exist between the species constituting the Staph. albus group. After viability had been checked the minimum inhibitory concentrations (MIC) of the organisms were read in the usual way. Strains were considered to be susceptible when the MIC did not exceed 16 mg/l in the case of cephradine, cephalexin, and cefuroxime, and 4 mg/l in the case of cephaloridine.
Material and methods

Results
All of the strains of Staph. aureus produced coagulase and deoxyribonuclease. Thirty-eight of the 69 coagulase-negative strains were shown to be Staph. epidermidis and 31 were shown to be Staph. hominis.
The results of the MIC determinations are shown in Tables 1 to 3 and are summarised in Table 4 These results show that staphylococci cannot be assumed to be homogeneous in their behaviour in the presence of these drugs. They also show the necessity for testing individual drugs in this family.
Unless tests for susceptibility to drugs have some value in predicting what will happen in vivo, they are irrelevant in the clinical laboratory. The effect of osmotic support is shown to be variable, but we suggest that the testing of cell-wall-active drugs in a medium whose colloid osmotic pressure is similar to that of proteinaceous body fluids45 may represent a step towards greater relevance. In addition, the drug-resistant members of a methicillin-resistant culture grow more slowly at 37°C than at 30'C, and if the same is true for cultures resistant to cephalosporins, the use of lower incubation temperatures Effects of test conditions on susceptibility of staphylocccci to cephalosporins 207 would also be justified as it would hasten their detection in the laboratory.
The significance of these laboratory studies with regard to their ability to predict therapeutic efficacy requires further investigation, but in a recent study of Staph. aureus in burns,'3 100% of burns showed elimination or reduction of strains that had been shown to be sensitive at both 30°C and 37°C, whereas only 80 % showed elimination or reduction of strains shown to be sensitive at 37°C but resistant at 30°C, using 500 mg flucloxacillin six-hourly in each case. The demonstration of 'resistance' of strains to cell-wall-active antibiotics in vitro at 30°C may indicate that successful therapy with the drug tested is more likely if a higher dosage is used.
